According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.53. In 2022 the company made an earnings per share (EPS) of -$97.29 a decrease over its 2021 EPS that were of -$35.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.53 | -94.32% |
2022 | -$97.29 | 177.97% |
2021 | -$35.00 | -31.1% |
2020 | -$50.80 | 70.91% |
2019 | -$29.72 |